The role of cytoreductive surgery and HIPEC for the treatment of primary and secondary peritoneal malignancies—experience from a tertiary care center in Germany
Crossref DOI link: https://doi.org/10.1007/s00423-024-03309-9
Published Online: 2024-04-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Reese, Mikko
Eichelmann, Ann-Kathrin
Nowacki, Tobias M.
Pascher, Andreas
Sporn, Judith C.
Text and Data Mining valid from 2024-04-08
Version of Record valid from 2024-04-08
Article History
Received: 28 December 2023
Accepted: 3 April 2024
First Online: 8 April 2024
Declarations
:
: The authors declare no competing interests.